Causal Responsibility Division of Chronological Continuous Treatment Based on Change-Point Detection.

This paper introduces a novel approach, called causal relation quantification, based on change-point detection to address the issue of harmonic responsibility division in power systems. The proposed method focuses on determining the causal effect of chronological continuous treatment, enabling the identification of crucial treatment intervals. Within each interval, three propensity-score-based algorithms are executed to assess their respective causal effects. By integrating the results from each interval, the overall causal effect of a chronological continuous treatment variable can be calculated. This calculated overall causal effect represents the causal responsibility of each harmonic customer. The effectiveness of the proposed method is evaluated through a simulation study and demonstrated in an empirical harmonic application. The results of the simulation study indicate that our method provides accurate and robust estimates, while the calculated results in the harmonic application align closely with the real-world scenario as verified by on-site investigations.

RDH1 suppresses adiposity by promoting brown adipose adaptation to fasting and re-feeding.

RDH1 is one of the several enzymes that catalyze the first of the two reactions to convert retinol into all-trans-retinoic acid (atRA). Here, we show that Rdh1-null mice fed a low-fat diet gain more weight as adiposity (17% males, 13% females) than wild-type mice by 20 weeks old, despite neither consuming more calories nor decreasing activity. Glucose intolerance and insulin resistance develop following increased adiposity. Despite the increase in white fat pads, epididymal white adipose does not express Rdh1, nor does muscle. Brown adipose tissue (BAT) and liver express Rdh1 at relatively high levels compared to other tissues. Rdh1 ablation lowered body temperatures during ambient conditions. Given the decreased body temperature, we focused on BAT. A lack of differences in BAT adipogenic gene expression between Rdh1-null mice and wild-type mice, including Pparg, Prdm16, Zfp516 and Zfp521, indicated that the phenotype was not driven by brown adipose hyperplasia. Rather, Rdh1 ablation eliminated the increase in BAT atRA that occurs after re-feeding. This disruption of atRA homeostasis increased fatty acid uptake, but attenuated lipolysis in primary brown adipocytes, resulting in increased lipid content and larger lipid droplets. Rdh1 ablation also decreased mitochondrial proteins, including CYCS and UCP1, the mitochondria oxygen consumption rate, and disrupted the mitochondria membrane potential, further reflecting impaired BAT function, resulting in both BAT and white adipose hypertrophy. RNAseq revealed dysregulation of 424 BAT genes in null mice, which segregated predominantly into differences after fasting vs after re-feeding. Exceptions were Rbp4 and Gbp2b, which increased during both dietary conditions. Rbp4 encodes the serum retinol-binding protein-an insulin desensitizer. Gbp2b encodes a GTPase. Because Gbp2b increased several hundred-fold, we overexpressed it in brown adipocytes. This caused a shift to larger lipid droplets, suggesting that GBP2b affects signaling downstream of the ß-adrenergic receptor during basal thermogenesis. Thus, Rdh1-generated atRA in BAT regulates multiple genes that promote BAT adaptation to whole-body energy status, such as fasting and re-feeding. These gene expression changes promote optimum mitochondria function and thermogenesis, limiting adiposity. Attenuation of adiposity and insulin resistance suggests that RDH1 mitigates metabolic syndrome.

Perceived Efficacy, Reduced Prescription Drug Use, and Minimal Side Effects of Cannabis in Patients with Chronic Orthopedic Pain.

Introduction: Although cannabis is widely used for the treatment of chronic pain, most research relies on patient self-report and few studies have objectively quantified its efficacy and side effects. Extant inventories for measuring cannabis use were not designed to capture the medically relevant features of cannabis use, but rather were designed to detect problematic use or cannabis use disorder. Thus, we sought to capture the medically relevant features of cannabis use in a population of patients with orthopedic pain and pair these data with objective measures of pain and prescription drug use. Materials and Methods: In this prospective observational study, orthopedic pain patients were enrolled in Pennsylvania's medical cannabis program by their treating pain management physician, received cannabis education from their physician at the time of certification, and purchased products from state-licensed cannabis retailers. Results: Medical cannabis use was associated with clinical improvements in pain, function, and quality of life with reductions in prescription drug use; 73% either ceased or decreased opioid consumption and 31% discontinued benzodiazepines. Importantly, 52% of patients did not experience intoxication as a side effect of cannabis therapy. Significant clinical benefits of cannabis occurred within 3 months of initiating cannabis therapy and plateaued at the subsequent follow-ups. Conclusions: This work provides a direct relationship between the initiation of cannabis therapy and objectively fewer opioid and benzodiazepine prescriptions. Our work also identifies specific subpopulations of patients for whom cannabis may be most efficacious in reducing opioid consumption, and it highlights the importance of both physician involvement and patient self-titration in symptom management with cannabis.

Medical Cannabis Use Reduces Opioid Prescriptions in Patients With Chronic Back Pain.

Background This study investigates whether the use of medical cannabis (MC) in patients with chronic back pain is associated with a decreased opioid prescription. Methods The study included 186 patients with chronic back pain who were certified for MC use. The average morphine milligram equivalent (MME)/day of opioid prescriptions filled within the six months prior to MC certification was compared to that of six months after. Pain and disability questionnaires were distributed at three, six, and nine months post-certification. Results Patients who started at less than 15 MME/day and patients who started at greater than 15 MME/day decreased from 15.1 to 11.0 (n = 186, p < 0.01), 3.5 to 2---.1 (n = 134, p < 0.01), and 44.9 to 33.9 (n = 52, p < 0.01), respectively. Pain and disability scores were improved at follow-up as well. Conclusion MC use reduces opioid prescription for patients with chronic back pain and improves pain and disability scores.

Medical Cannabis Use Reduces Opioid Prescriptions in Patients With Osteoarthritis.

Background Osteoarthritis (OA) can result in significant pain, requiring pain management with opioids. Medical cannabis (MC) has the potential to be an alternative to opioids for chronic pain conditions. This study investigates whether MC used in the management of OA-related chronic pain can reduce opioid utilization. Methods Forty patients with chronic OA pain were certified for MC. Average morphine milligram equivalents (MME) per day of opioid prescriptions filled within the six months prior to MC certification was compared to that of the six months after. Visual analog scale (VAS) for pain and Global Health scores were measured at baseline, three, and six months post MC certification. Results Average MME/day decreased from 18.2 to 9.8 (n=40, p<0.05). The percentage of patients who dropped to 0 MME/day was 37.5%. VAS scores decreased significantly at three and six months, and Global Physical Health score increased significantly by three months. Conclusions MC reduces opioid prescription for patients with chronic OA pain and improves pain and quality of life.

Design and assessment of a common, multi-national public health informatics infrastructure to enable H1N1 influenza surveillance.

Public health organizations in different nations face similar needs for gathering and analyzing population health data to detect and manage infectious disease outbreaks, including outbreaks of the 2009 Novel H1N1 Influenza A virus or "swine flu." This paper presents our progress to date on the design and assessment of a multi-national public health informatics infrastructure for data collection and disease surveillance. This initial work, under the aegis of an open health tools collaborative, lays the foundation for best practices in patient care and public health preparedness in the national health IT sector. This multinational collaboration is the first to identify essential electronic health record (EHR) data sets as well as standard public health informatics indicators to electronically monitor a notifiable public health condition internationally.

Fat aussie--a new Alström syndrome mouse showing a critical role for ALMS1 in obesity, diabetes, and spermatogenesis.

Mutations in the human ALMS1 gene are responsible for Alström syndrome, a disorder in which key metabolic and endocrinological features include childhood-onset obesity, metabolic syndrome, and diabetes, as well as infertility. ALMS1 localizes to the basal bodies of cilia and plays a role in intracellular trafficking, but the biological functions of ALMS1 and how these relate to the pathogenesis of obesity, diabetes, and infertility remain unclear. Here we describe a new mouse model of Alström syndrome, fat aussie, caused by a spontaneous mutation in the Alms1 gene. Fat aussie (Alms1 foz/foz) mice are of normal weight when young but, by 120 d of age, they become obese and hyperinsulinemic. Diabetes develops in Alms1 foz/foz mice accompanied by pancreatic islet hyperplasia and islet cysts. Female mice are fertile before the onset of obesity and metabolic syndrome; however, male fat aussie mice are sterile due to a progressive germ cell loss followed by an almost complete block of development at the round-to-elongating spermatid stage of spermatogenesis. In conclusion, Alms1 foz/foz mouse is a new animal model in which to study the pathogenesis of the metabolic and fertility defects of Alström syndrome, including the role of ALMS1 in appetite regulation, pathogenesis of the metabolic syndrome, pancreatic islet physiology, and spermatogenesis.

Australia's notifiable disease status, 2008: annual report of the National Notifiable Diseases Surveillance System.

In 2008, 65 communicable diseases and conditions were nationally notifiable in Australia. States and territories reported a total of 160,508 notifications of communicable diseases to the National Notifiable Diseases Surveillance System, an increase of 9% on the number of notifications in 2007. In 2008, the most frequently notified diseases were sexually transmissible infections (69,459 notifications, 43% of total notifications), vaccine preventable diseases (34,225 notifications, 21% of total notifications) and gastrointestinal diseases (27,308 notifications, 17% of total notifications). There were 18,207 notifications of bloodborne diseases; 8,876 notifications of vectorborne diseases; 1,796 notifications of other bacterial infections; 633 notifications of zoonoses and 4 notifications of quarantinable diseases.

The risk of malaria in travelers to India.

BACKGROUND: Several countries have reported a decline in malaria cases imported by travelers returning from India. METHODS: We collected data on imported malaria for the period 1992 to 2005 from nine countries. Traveler statistics denominator data were obtained from the Indian Ministry of Tourism. RESULTS: The malaria case numbers declined from 93 cases per 100,000 travelers in 1992 to 19 cases per 100,000 travelers in 2005. The proportion of Plasmodium falciparum decreased steadily throughout the years. The proportion of Plasmodium vivax accounts for more than 80% of all cases of malaria in travelers to India. Deaths due to malaria were rare; only the UK and the United States reported deaths, a total of 16, between 1992 and 2005. The high-risk areas for malaria in India can be clearly identified using endemic malaria data. High-risk states are Chhattisgarh, Orissa, Jharkhand, West Bengal, Goa (mainly P vivax), and the states east of Bangladesh. CONCLUSIONS: The decreasing incidence of malaria in travelers to India and the high proportion of P vivax support the current change in guidelines in some European countries advocating the use of the standby emergency self-treatment strategy or bite precautions plus awareness of risk instead of chemoprophylaxis. Otherwise in high-risk states, chemoprophylaxis should still be considered particularly in high-transmission seasons.

Australia's notifiable disease status, 2007: annual report of the National Notifiable Diseases Surveillance System.

In 2007, 69 diseases and conditions were nationally notifiable in Australia. States and territories reported a total of 146,991 notifications of communicable diseases to the National Notifiable Diseases Surveillance System, an increase of 5% on the number of notifications in 2006. In 2007, the most frequently notified diseases were sexually transmissible infections (62,474 notifications, 43% of total notifications), gastrointestinal diseases (30,325 notifications, 21% of total notifications) and vaccine preventable diseases (25,347 notifications, 17% of total notifications). There were 19,570 notifications of bloodborne diseases; 6,823 notifications of vectorborne diseases; 1,762 notifications of other bacterial infections; 687 notifications of zoonoses and 3 notifications of quarantinable diseases.

Annual report of the National Influenza Surveillance Scheme, 2007.

The year 2007 saw the most severe influenza season since national reporting of influenza began in 2001. Early in the season the National Incident Room was activated to provide effective national surveillance, reporting and management of the 2007 seasonal influenza outbreak. A surveillance team were tasked with establishing enhanced surveillance for the 2007 season and investigating unusual events in this outbreak. Key data required to comprehensively describe the number of cases, morbidity, mortality and virology of the influenza outbreak and the possible sources of these data were identified. In 2007 the number of laboratory-confirmed notifications for influenza was 3.1 times higher than the five-year mean. Forty-four per cent of notifications occurred in Queensland. High notification rates were reflected in an increase in presentations with influenza-like illness to sentinel general practices and Emergency Departments. Notifications and notification rates were highest in the 0-4 and 5-9 years age groups, possibly due to a bias towards testing in these age groups. The clinical morbidity of the infection in terms of complications or most affected groups cannot be determined but anecdotal reports indicate this season may have impacted young adults more than is usual. The available data suggest influenza has caused a significant burden on workplaces and the health care system as indicated by data on absenteeism and presentations for health care. The proportion of H1 strains of influenza circulating varied across Australia but was higher than 2006 in most jurisdictions. In 2007, 1,406 influenza isolates from Australia were antigenically analysed at the World Health Organization Collaborating Centre for Reference and Research on Influenza in Melbourne: 58.7% were A(H3N2), 34.4% were A(H1N1) and 6.9% were influenza B viruses. Antigenic drift away from the vaccine strain A/Wisconsin/67/2005 was observed with the A(H3N2) viruses and was also seen with most of the A(H1N1) viruses when compared with the vaccine strain A/New Caledonia/20/99. The small number of influenza B viruses examined were predominately of the B/Yamagata-lineage. Monitoring influenza through the National Incident Room during the 2007 season offered an excellent opportunity to conduct enhanced surveillance under conditions that were real and potentially serious but not an emergency. It enabled the current state of our surveillance systems to be assessed and opportunities for improvement to be identified.

Communicable Diseases Network Australia National Arbovirus and Malaria Advisory Committee annual report, 2006-07.

This report describes the epidemiology of mosquito-borne disease in Australia for the mosquito-borne disease season 1 July 2006 to 30 June 2007, which was moderately low compared to previous seasons. Ross River virus (RRV) infections (55%), Barmah Forest virus (BFV) infections (29%) and overseas acquired malaria (11%) were the most common mosquito-borne diseases reported in 2006-07. The number, proportion and rate of national BFV notifications were the second highest on record since 1998-99. The Northern Territory reported the highest BFV notification rate this season. BFV notification rates were the highest in the 40-59 year age groups when compared to other age groups. The number, proportion and rate of RRV notifications were moderately low this season compared with previous seasons. The highest RRV rate was reported by Western Australia from the Kimberley region. The highest age-specific RRV notification rate was observed in the 40-59 year age groups. Locally acquired dengue virus notifications were low this season compared to previous seasons, with a small outbreak of dengue serotype 3 in 39 cases confined to the greater Townsville region. There were 640 notifications of malaria in 2006-07 of which none were reported as locally acquired. This was the third highest number of malaria notifications since 2001. Plasmodium falciparum was reported as the infecting species in 47% of the malaria notifications and Plasmodium vivax for 40% of cases. Young adolescents and adults in the 15-29 year age group had the highest number of cases accounting for 32% of notifications. Sentinel chicken surveillance data for flaviviruses and sentinel pig surveillance data for Japanese encephalitis virus are also reported.

Australia's notifiable diseases status, 2006: annual report of the National Notifiable Diseases Surveillance System.

In 2006, 66 diseases and conditions were nationally notifiable in Australia. States and territories reported a total of 138,511 cases of communicable diseases to the National Notifiable Diseases Surveillance System: an increase of 10.4% on the number of notifications in 2005. In 2006, the most frequently notified diseases were sexually transmissible infections (57,941 notifications, 42% of total notifications), gastrointestinal diseases (27,931 notifications, 20% of total notifications) and vaccine preventable diseases (22,240 notifications, 16% of total notifications). There were 19,111 notifications of bloodborne diseases; 8,606 notifications of vectorborne diseases; 1,900 notifications of other bacterial infections; 767 notifications of zoonoses and 3 notifications of quarantinable diseases.

Australia's notifiable diseases status, 2005: annual report of the National Notifiable Diseases Surveillance System.

In 2005, 60 diseases and conditions were nationally notifiable in Australia. States and territories reported a total of 125,461 cases of communicable diseases to the National Notifiable Diseases Surveillance System: an increase of 10% on the number of notifications in 2004. In 2005, the most frequently notified diseases were sexually transmissible infections (51,557 notifications, 41% of total notifications), gastrointestinal diseases (29,422 notifications, 23%) and bloodborne diseases (19,278 notifications, 15%). There were 17,753 notifications of vaccine preventable diseases; 4,935 notifications of vectorborne diseases; 1,826 notification of other bacterial infections (legionellosis, leprosy, meningococcal infections and tuberculosis) and 687 notifications of zoonotic diseases.

Communicable Diseases Network Australia National Arbovirus and Malaria Advisory Committee annual report, 2005-06.

This report describes the epidemiology of mosquito-borne disease in Australia for the mosquito-borne disease season 1 July 2005 to 30 June 2006, in which the second largest number of notifications since 1995-96 was reported. Ross River virus (RRV) infections (66%), Barmah Forest virus (BFV) infections (23%) and malaria (9%) were the most common mosquito-borne diseases reported in 2005-06. National RRV notifications were the fifth largest on record. The Northern Territory had the highest rate of RRV notifications and the peak notification rate (in January 2006) was the third highest since 2000. National BFV notification rates were the highest on record. The Northern Territory also reported the highest BFV notification rate this season, peaking in February-March 2006, which was the highest reported BFV notification rate on record. BFV notification rates were significantly higher in teenagers compared to previous seasons. There were 731 notifications of malaria in 2005-06 of which none was reported as locally acquired. This was the third highest reporting period for malaria notifications since 2000. In contrast to previous years in which Plasmodium vivax was the predominant species, Plasmodium falciparum was reported as the infecting species in 45 per cent of the malaria notifications and Plasmodium vivax for 42 per cent of cases. Young adults in the 20-24 year age group had the highest number of cases and children in the 5-9 year age group accounted for 22 per cent of notifications. There were two cases of Kunjin virus (KUNV) infection and one case of Murray Valley encephalitis virus (MVEV) infection reported in 2005-06, all from Western Australia. Sentinel chicken surveillance data for flaviviruses and sentinel pig surveillance data for Japanese encephalitis virus are reported. There were 200 notifications of dengue virus (DENV) infection in 2005-06, of which 46 per cent (n = 92) was reported as having been acquired overseas. Dengue serotypes 2 and 3 were detected in two outbreaks of locally-acquired dengue in Queensland this season.

Australia's notifiable diseases status, 2004, annual report of the National Notifiable Diseases Surveillance System.

In 2004, 60 diseases and conditions were nationally notifiable in Australia. States and Territories reported a total of 110,929 cases of communicable diseases to the National Notifiable Diseases Surveillance System (NNDSS): an increase of 4 per cent on the number of notifications in 2003. In 2004, the most frequently notified diseases were sexually transmissible infections (46,762 cases; 42% of total notifications), gastrointestinal diseases (25,247 cases; 23% of total notifications) and bloodborne diseases (19,191 cases; 17% of total notifications). There were 13,206 notifications of vaccine preventable diseases, 6,000 notifications of vectorborne diseases, 1,799 notifications of other bacterial infections (includes, legionellosis, leprosy, meningococcal infections and tuberculosis) and 877 notifications of zoonotic diseases.

Communicable Diseases Network Australia: National Arbovirus and Malaria Advisory Committee annual report 2004-05.

This report describes the epidemiology of mosquito-borne disease in Australia for the mosquito-borne disease season 1 July 2004 to 30 June 2005. Ross River virus (RRV) infections (45%), Barmah Forest virus (BFV) infections (30%) and malaria (19%) were the most common mosquito-borne diseases reported in 2004-05. The Northern Territory had the highest rate of RRV notifications and the peak notification rate (in February 2005) was 54 per cent less than the previous season. The Northern Territory also reported the highest BFV notification rate this season, peaking in April 2005, which was the second highest reported BFV notification rate since 1998. National RRV and BFV notification rates were highest in the 45-49 year age group. There were 799 notifications of malaria in 2004-05 of which none were reported as locally acquired. This was the third highest reporting season for malaria notifications since 1998. In contrast to previous years in which Plasmodium vivax was the predominant species, Plasmodium falciparum was reported as the infecting species in 57 per cent of the malaria notifications and Plasmodium vivax for 34 per cent of cases. Children in the 5-9 year age group had the highest number of cases compared to previous years in which the peak number of cases tended to be in young adult age groups. There were four cases of Kunjin virus (KUNV) and two cases of Murray Valley encephalitis virus (MVEV) reported in 2004-05. Sentinel chicken surveillance data for flaviviruses and sentinel pig surveillance data for Japanese encephalitis virus are reported. There were 188 notifications of dengue virus infection (DENV) in 2004-05, of which 46 per cent (n=86) were reported as having been acquired overseas. Dengue serotype 4 was the most frequently reported type, accounting for 32 per cent of cases (n=60).